Waverley Pharma, Inc. WAVE

TSXV · Canada · Health Technology

CAD 0.01000.00 (0.00%)

Market closed· Sep 21, 2026, 6:56 PM UTC· CAD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Waverley Pharma, Inc. WAVE

TSXV · Canada · Health Technology

CAD 0.01000.00 (0.00%)

Market closed· Sep 21, 2026, 6:56 PM UTC· CAD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-33.33% · 6MFull-screen chart

Open CAD 0.010000High CAD 0.010000Low CAD 0.010000Close CAD 0.010000Volume 0

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: CAD 0.0100
Day range: CAD 0.0100 – CAD 0.0100
52-week range: CAD 0.0100 – CAD 0.0400
Volume: 5.00K
Market cap: CAD 540.00K
Avg. volume (1Y): 1.99K

Performance

1 week

0.00%

1 month

-50.00%

3 months

-60.00%

6 months

-33.33%

Year to date

-50.00%

1 year

-50.00%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: Canada
Exchange: TSXV
Shares outstanding: 54.00M
ISIN: CA94357L1058
Beta: 1.31

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceJul 17, 2026

Waverley Pharma Announces Chief Financial Officer Change

Waverley Pharma Inc. ("Waverley Pharma" or the "Company") (TSXV: WAVE), a Canadian pharmaceutical company, today announced that Haaris Uddin is resigning from his role as Chief Financial Officer ("CFO") of the Company effective July 24, 2026 in order to pursue a professional opportunity outside the pharmaceutical industry.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.